Biogen

Gold Sponsor

At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain. We routinely post information that may be important to investors on our website at www.biogen.com.


website

World Orphan Drug Congress

 

The World Orphan Drug Congress provides you with a one stop progressive scientific and strategic solution to the orphan drugs industry.

 

 

Events


World Orphan Drug Congress

Rare Disease Day

 

 

Contact us


To sponsor or exhibit:
Michael Hodge

Michael.hodge@terrapinn.com


To speak:
Wing-Yun Cheung

wing-yun.cheung@terrapinn.com


Nadia Konneh

nadia.konneh@terrapinn.com